| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 1 | 1 | 1 | 11 | 8 | 8 | 12 | 11 |
| Expenses | 1 | 1 | 1 | 2 | 3 | 6 | 5 | 2 | 0 | 1 | 10 | 8 | 7 | 10 | 9 |
| EBITDA | -0 | -0 | -0 | -0 | -0 | -2 | -1 | -1 | 0 | 0 | 1 | 1 | 1 | 2 | 2 |
| Operating Profit % | -9 % | -14 % | -14 % | -26 % | -18 % | -44 % | -42 % | -148 % | 25 % | -6 % | 4 % | 5 % | 9 % | 12 % | 14 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -1 | -1 | -2 | -2 | -1 | 0 | -0 | 1 | 0 | 1 | 2 | 2 |
| Tax | -0 | -0 | 0 | -0 | -0 | -1 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | 0 | -0 | 0 | 0 | 0 | 1 | 1 |
| EPS in ₹ | -0.25 | -0.26 | -0.22 | -0.58 | -0.50 | -1.87 | -1.55 | -1.08 | 0.17 | -0.14 | 0.29 | 0.22 | 0.32 | 0.80 | 0.66 |
EIKO Lifesciences
EIKO Lifesciences
50.99
-0.76
(-1.47%)
Key Fundamentals
Market Cap
71.00 Cr
EPS
1.62
PE Ratio
22.76
Dividend Yield
0.00 %
Industry
Chemicals 52 Week High
74.88
52 Week Low
42.00
PB Ratio
1.23
Debt to Equity
0.05
Sector
Specialty Chemicals Actual
Company News
View All News
Lenus Finvest Acquires Additional 0.05% Stake in Eiko LifeSciences, Total Holding Reaches 17.24%Sep 04, 2025
Lenus Finvest Private Limited acquired 7,444 equity shares representing 0.05% of Eiko LifeSciences Limited through open market purchases between September 2-3, 2025. The acquisition increased Lenus Finvest's total shareholding from 23,58,028 shares (17.19%) to 23,65,472 shares (17.24%) in the BSE-listed company. Lenus Finvest belongs to the promoter group of Eiko LifeSciences. The target company has a total equity share capital of Rs. 13,72,08,540 comprising 1,37,20,854 equity shares of Rs. 10 each.
Eiko Lifesciences Approves Increase in Authorized Share Capital from Rs. 14 Crore to Rs. 20 Crore
Jul 29, 2025
Jul 29, 2025Eiko Lifesciences Limited's Board of Directors approved an increase in the company's authorized share capital from Rs. 14 crore to Rs. 20 crore. The capital structure will change from 1.4 crore equity shares of Rs. 10 each to 2 crore equity shares of Rs. 10 each. The decision requires amendments to the company's Memorandum of Association, specifically substituting Clause V to reflect the new authorized capital of Rs. 20 crore divided into 2 crore equity shares. The proposal is subject to shareholder approval. No changes to the Articles of Association are required.
Eiko Lifesciences Appoints New Whole Time Director, Re-appoints Two Independent DirectorsJul 29, 2025
Jul 29, 2025Eiko Lifesciences Limited's board approved the appointment of Sumukh Prabhakar Vartak as additional Whole Time Director for 5 years starting July 29, 2025. Vartak holds an MBA and has over 21 years of experience in Active Pharmaceutical Ingredients, specializing in marketing strategies for regulated and semi-regulated markets. The board also approved re-appointment of Kajal Kothari as Independent Director for another 5-year term beginning September 9, 2025. Kothari, aged 35, holds a Bachelor's in Pharmacy and is co-founder of Fresh Box Media. Additionally, Rajkumar Baheti was re-appointed as Independent Director for 5 years starting February 10, 2026. Baheti, aged 53, has over 20 years of experience in shipping and logistics with a Bachelor's in Commerce. All appointments require shareholder approval.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,542.70 | #1 1,54,997.80 | 71.22 | 13,387.50 | 6.91 | #1 2,096 | 18.69 | 60.29 | |
3,169.40 | 94,559.50 | 65.65 | 14,825.80 | 12.13 | 1,251 | 71.41 | 73.26 | |
3,718.40 | 41,133.30 | 65.55 | 4,853.20 | 10.61 | 546 | 70.37 | 53.30 | |
5,108.80 | 25,898.30 | 73.78 | 2,393.10 | 12.83 | 289 | #1 128.91 | 67.76 | |
1,770.20 | 24,215.20 | 39.78 | 8,365.80 | 7.84 | 697 | -44.54 | 41.31 | |
4,526.80 | 19,893.20 | 49.52 | #1 15,339.40 | 10.81 | 479 | -37.72 | 45.20 | |
1,695.10 | 17,670.80 | 41.29 | 2,292.50 | 18.24 | 405 | 23.75 | 46.87 | |
5,952.00 | 17,158.70 | #1 31.00 | 5,692.40 | #1 18.99 | 499 | 30.75 | 40.83 | |
4,520.70 | 13,800.10 | 33.47 | 2,366.70 | 7.83 | 411 | 3.35 | 39.41 | |
374.80 | 13,653.50 | 57.30 | 7,285.40 | 14.16 | 331 | -68.61 | 43.06 |
Growth Rate
Revenue Growth
269.23 %
Net Income Growth
-163.89 %
Cash Flow Change
984.85 %
ROE
-101.25 %
ROCE
-103.12 %
EBITDA Margin (Avg.)
-120.90 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2025 |
| Total Assets | 11 | 9 | 12 | 66 |
| Fixed Assets | 2 | 2 | 2 | 23 |
| Current Assets | 6 | 4 | 5 | 33 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 3 | 2 | 0 | 7 |
| Other Assets | 6 | 6 | 10 | 36 |
| Total Liabilities | 11 | 9 | 12 | 66 |
| Current Liabilities | 5 | 4 | 9 | 6 |
| Non Current Liabilities | 1 | 0 | 2 | 3 |
| Total Equity | 6 | 5 | 1 | 57 |
| Reserve & Surplus | 2 | 1 | -1 | 43 |
| Share Capital | 4 | 4 | 4 | 14 |
Cash Flow
| Cash Flow | 2017 | 2018 | 2019 | 2020 | 2025 |
| Net Cash Flow | 0 | 0 | -1 | -0 | -2 |
| Investing Activities | 0 | 0 | -0 | -1 | -11 |
| Operating Activities | 0 | 0 | 0 | -0 | 3 |
| Financing Activities | 0 | 0 | -1 | 1 | 7 |
Share Holding
| % Holding | Mar 2021 | May 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Jan 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 |
| Promoter | 21.37 % | 9.82 % | 9.82 % | 9.82 % | 9.82 % | 10.59 % | 13.48 % | 14.68 % | 23.03 % | 23.73 % | 23.73 % | 24.23 % | 24.23 % | 24.23 % | 24.23 % | 24.40 % | 24.40 % | 31.27 % | 31.27 % | 31.27 % | 36.23 % | 36.74 % | 37.11 % | 37.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 59.91 % | 63.89 % | 63.93 % | 64.04 % | 63.97 % | 62.09 % | 53.44 % | 52.95 % | 55.17 % | 53.87 % | 53.34 % | 54.94 % | 54.06 % | 53.96 % | 51.62 % | 48.92 % | 49.05 % | 45.17 % | 44.97 % | 44.82 % | 44.38 % | 44.35 % | 43.49 % | 43.37 % |
| Others | 18.72 % | 26.29 % | 26.26 % | 26.14 % | 26.21 % | 27.32 % | 33.08 % | 32.36 % | 21.80 % | 22.40 % | 22.93 % | 20.83 % | 21.71 % | 21.80 % | 24.15 % | 26.68 % | 26.55 % | 23.56 % | 23.76 % | 23.91 % | 19.39 % | 18.91 % | 19.40 % | 19.47 % |
| No of Share Holders | 298 | 381 | 380 | 389 | 420 | 537 | 585 | 809 | 1,142 | 1,874 | 2,155 | 2,722 | 2,637 | 2,728 | 3,000 | 2,938 | 3,140 | 3,199 | 3,456 | 3,565 | 3,336 | 3,322 | 3,203 | 3,150 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Oct 2025 |  Quarterly Result Announcement | NA | 31 Oct 2025 | 51.75 | 50.75 |
| 01 Mar 2021 |  Change Of Name | NA | 01 Mar 2021 | 41.70 | 41.70 |
| 07 Jul 2023 |  Rights | 2:3 | 07 Jul 2023 | 61.28 | 67.51 |
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 57.61 | 58.00 |
| 19 Oct 2024 | Quarterly Result Announcement | NA | 19 Oct 2024 | 67.35 | 63.26 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 57.03 | 48.47 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 49.08 | 49.03 |
| 29 Jul 2025 | Quarterly Result Announcement | NA | 29 Jul 2025 | 54.22 | 51.79 |
| 05 Sept 2025 | Annual General Meeting | NA | 05 Sept 2025 | 51.79 | 51.34 |
Announcements
Board Meeting Intimation for Meeting Scheduled On Friday 31St October 20252 days ago
2 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20188 days ago
8 days agoClosure of Trading WindowSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 06, 2025
Sep 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Sep 05, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 04, 2025
Sep 04, 2025Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 (The Listing Regulations)Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Reg. 34 (1) Annual Report.Jul 30, 2025
Jul 30, 2025Reg 34 (1) - Annual Report For The FY 2024-25.Jul 29, 2025
Jul 29, 2025Notice Of The 48Th AGM Of The Company For The Financial Year 2024-25Jul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 29, 2025
Jul 29, 2025Board Meeting Outcome for Outcome Of The Board MeetingJul 29, 2025
Jul 29, 2025Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Jul 29, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 24, 2025
Jul 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Clarification On Price MovementJul 04, 2025
Jul 04, 2025Clarification sought from Eiko Lifesciences LtdJul 04, 2025
Jul 04, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Revised Financial Results For Quarter And Year Ended 31St March 2025May 14, 2025
May 14, 2025Revise Outcome Of Board Meeting Dated 14.05.2025May 14, 2025
May 14, 2025Appointment Of Secretarial AuditorMay 14, 2025
May 14, 2025Appointment Of Internal AuditorMay 14, 2025
May 14, 2025Results For Quarter And Year Ended 31St March 2025May 14, 2025
May 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 14.05.2025May 14, 2025
May 14, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
May 14, 2025Board Meeting Intimation for Approval Of Financial Results And Other AgendasMay 07, 2025
May 07, 2025Submission Of Initial And Annual Disclosure As Per SEBI Circular- - Fund Raising By Issuance Issuance Of Debt Securities By Large CorporatesApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 28, 2025
Mar 28, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 26, 2025
Mar 26, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 18, 2025
Mar 18, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 18, 2025
Mar 18, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 17, 2025
Mar 17, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 13, 2025
Mar 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMar 12, 2025
Mar 12, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 11, 2025
Mar 11, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 08, 2025
Mar 08, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 07, 2025
Mar 07, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
Mar 05, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 04, 2025
Mar 04, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 03, 2025
Mar 03, 2025Technical Indicators
RSI(14)
Neutral 40.42
ATR(14)
Volatile 2.07
STOCH(9,6)
Neutral 29.84
STOCH RSI(14)
Neutral 37.98
MACD(12,26)
Bearish -0.16
ADX(14)
Weak Trend 10.06
UO(9)
Bearish 42.08
ROC(12)
Downtrend And Accelerating -4.69
WillR(14)
Oversold -80.77
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
